World's Best Scientists 2026 revealed!
Mehala Subramaniapillai

Mehala Subramaniapillai

Award Badge
Rising Stars
2025

D-Index & Metrics

Rising Stars

D-Index
37
Citations
6921
World Ranking
753
National Ranking
18

Psychology

D-Index
42
Citations
8585
World Ranking
7490
National Ranking
508

Research.com Recognitions

  • 2025 - Research.com Rising Stars Award

Overview

Mehala Subramaniapillai is affiliated with the University of Toronto in Canada and has a substantial publication record in the fields of Medicine, Psychology, and Neuroscience. Their research spans several subfields, including Biological Psychiatry, Pharmacology, Experimental and Cognitive Psychology, Psychiatry and Mental Health, and Neurology.

Their main topics of study involve diverse subjects, prominently featuring:

  • Tryptophan and brain disorders
  • Treatment of Major Depression
  • Long-Term Effects of COVID-19
  • Mental Health Research Topics
  • COVID-19 and Mental Health
  • Bipolar Disorder and Treatment
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Among their recent notable papers are:

  • Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis (2021), published in Brain Behavior and Immunity
  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (2021), published in American Journal of Psychiatry
  • Onset and frequency of depression in post-COVID-19 syndrome: A systematic review (2021), published in Journal of Psychiatric Research
  • Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries (2021), published in Journal of Affective Disorders
  • Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death (2021), published in JAMA Psychiatry

They frequently publish in the following venues:

  • Journal of Affective Disorders
  • Psychiatry Research
  • Journal of Psychiatric Research
  • CNS Spectrums
  • Brain Behavior and Immunity

Subramaniapillai has collaborated extensively with a number of researchers, including:

  • Roger S. McIntyre
  • Joshua D. Rosenblat
  • Rodrigo B. Mansur
  • Yena Lee
  • Roger Ho

Best Publications

  • Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis

    Unknown

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review

    Yena Lee;Renee-Marie Ragguett;Rodrigo B. Mansur;Justin J. Boutilier

  • Onset and frequency of depression in post-COVID-19 syndrome: A systematic review.

    Olivier Renaud-Charest;Leanna M.W. Lui;Sherry Eskander;Felicia Ceban

  • Cognitive impairment in major depressive disorder.

    Zihang Pan;Caroline Park;Elisa Brietzke;Hannah Zuckerman

  • Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries.

    Yena Lee;Leanna M.W. Lui;David Chen-Li;Yuhua Liao

  • Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.

    Felicia Ceban;Felicia Ceban;Danica Nogo;Isidro P. Carvalho;Yena Lee

  • Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.

    Elisa Brietzke;Elisa Brietzke;Rodrigo B. Mansur;Mehala Subramaniapillai;Vicent Balanzá-Martínez

  • Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.

    Roger S McIntyre;Mehala Subramaniapillai;Yena Lee;Yena Lee;Zihang Pan;Zihang Pan

  • The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.

    Roger S. McIntyre;Isabelle P. Carvalho;Leanna M.W. Lui;Amna Majeed

  • The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

    Roger S. McIntyre;Roger S. McIntyre;Michael W. Best;Christopher R. Bowie;Christopher R. Bowie;Nicole E. Carmona

  • Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.

    Rodrigo B. Mansur;Rodrigo B. Mansur;Juhie Ahmed;Danielle S. Cha;Hanna O. Woldeyohannes

  • The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder

    Bing Cao;Caroline Park;Mehala Subramaniapillai;Yena Lee;Yena Lee

  • Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

    Carola Rong;Caroline Park;Joshua D. Rosenblat;Mehala Subramaniapillai

  • Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

    Julia A. Hamer;Daniela Testani;Rodrigo B. Mansur;Yena Lee

  • Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.

    Yena Lee;Joshua D. Rosenblat;JungGoo Lee;Nicole E. Carmona

  • Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

    Susan Ling;Susan Ling;Felicia Ceban;Leanna M W Lui;Yena Lee

  • Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

    Unknown

  • The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.

    Roger S McIntyre;Roger S McIntyre;Nelson B Rodrigues;Yena Lee;Orly Lipsitz

  • The Mental Health Effects of COVID-19 on Health Care Providers in China.

    Kangguang Lin;Bing Xiang Yang;Dan Luo;Qian Liu

  • Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents

    Carola Rong;Nicole E Carmona;Yena L Lee;Renee-Marie Ragguett

  • Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis

    Bing Cao;Yan Chen;Elisa Brietzke;Danielle Cha

  • The effect of caloric restriction on working memory in healthy non-obese adults.

    Emilie Leclerc;Alisson Paulino Trevizol;Ruth B Grigolon;Mehala Subramaniapillai

Frequent Co-Authors

Rodrigo B. Mansur
Rodrigo B. Mansur University Health Network
Roger C.M. Ho
Roger C.M. Ho National University of Singapore
Maj Vinberg
Maj Vinberg University of Copenhagen
Christopher R. Bowie
Christopher R. Bowie Queen's University
Andrea Fagiolini
Andrea Fagiolini University of Siena
David J. Castle
David J. Castle University of Tasmania
Ana González-Pinto
Ana González-Pinto University of the Basque Country
Catherine J. Harmer
Catherine J. Harmer University of Oxford
Allan H. Young
Allan H. Young King's College London
Robert D. Levitan
Robert D. Levitan Centre for Addiction and Mental Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying psychology can open diverse doors in both academic and applied settings. For those seeking the highest level of expertise, many universities now offer flexible phd programs for psychology that prepare graduates for advanced research, teaching, and clinical roles.

Specializations are also widely available. For instance, students interested in the intersection of law and mental health might explore accredited online phd forensic psychology degrees. These programs are ideal for those aiming to consult within legal systems or criminal investigations.

Another in-demand path is school psychology. Candidates can choose from nasp approved school psychology programs online, which allow you to earn credentials recognized for school-based positions nationwide.

If you want a faster route to advancement or licensure, consider the best one-year online master’s in psychology degree programs. These intensive offerings can help you develop practical skills or begin work toward a doctoral track in much less time.

Best Scientists Citing Mehala Subramaniapillai

Trending Scientists